The Gary Null Show - 08.04.22

Videos: Neil Oliver – ‘…they’re herding people like sheep… Large Observational Study On COVID-19 Vaccines Impact of Women’s Menstrual Cycles Post Vaccination – Trial Site News The Dark Side of Electric Cars – Jhonny Harris  4.How The US Stole The Philippines – Jhonny Harris    Cardamonin shows promise for treating aggressive breast cancer Florida A&M University, August 3, 2022 Cardamonin—a natural compound found in the spice cardamom and other plants—could have therapeutic potential for triple-negative breast cancer, according to a new study using human cancer cells. The findings also show that the compound targets a gene that helps cancer cells elude the immune system About 10-15% of breast cancers are triple-negative, which means they don’t have receptors for estrogen or progesterone and don’t make excess amounts of a protein called HER2. These tumors are difficult to treat because they don’t respond to the hormone-based therapies used for other types of breast cancer. They also tend to be more aggressive and have a higher mortality rate than other breast cancers. “The fact that cardamonin has been used for centuries as a spice and, more recently, as a supplement shows that its intake is safe and may bring health benefits,” said Mendonca. “Our research shows that cardamonin holds potential for improving cancer therapy without as many side effects as other chemotherapeutic agents.” For the new study, the researchers investigated how cardamonin affected the expression of the programmed cell death ligand 1 (PD-L1) gene, which is found in tumor cells. PD-L1 is overexpressed during breast cancer progression and plays a critical role in helping breast cancer cells evade the body’s immune system. They found that cardamonin treatment caused a dose-dependent decrease in cell viability in both cell lines. It also reduced PD-L1 expression in the Caucasian cell line but not the African American cell line, indicating that cells from different races may respond differently to cardamonin because of genetic variations among races.  Persistent Low Wages Linked to Faster Memory Decline in Later Life Columbia University’s Mailman School of Public Health, August 2 2022Sustained low wages are associated with significantly faster memory decline, according to a new study by Columbia University Mailman School of Public Health. While low-wage jobs have been associated with health outcomes such as depressive symptoms, obesity, and hypertension, which are risk factors for cognitive aging, until now no prior studies had examined the specific relationship between low wages during working years and later-life cognitive functioning. The findings are published in the American Journal of Epidemiology.”Our research provides new evidence that sustained exposure to low wages during peak earning years is associated with accelerated memory decline later in life,” said Katrina Kezios, Ph.D., postdoctoral researcher in the Department of Epidemiology at Columbia University Mailman School of Public Health and first author. “This association was observed in our primary sample as well as in a validation cohort.”The researchers found that, compared with workers never earning low wages, sustained low-wage earners experienced significantly faster memory decline in older age. They experienced approximately one excess year of cognitive aging per a 10-year period; in other words, the level of cognitive aging experienced over a 10-year period by sustained low-wage earners would be what those who never earned low wages experienced in 11 years.”Our findings suggest that social policies that enhance the financial well-being of low-wage workers may be especially beneficial for cognitive health,” said senior author Adina Zeki Al Hazzouri, Ph.D., assistant professor of epidemiology at Columbia Mailman School and the Columbia Butler Aging Center. “Future work should rigorously examine the number of dementia cases and excess years of cognitive aging that could be prevent